26.02.2020 • NewsElaine Burridge

Valence Goes to Piper Sandler

Valence Goes to Piper Sandler
Valence Goes to Piper Sandler

Shareholders of The Valence Group have entered into a definite agreement to be acquired by Piper Sandler Companies. The transaction is expected to close in this year’s second quarter, subject to customary conditions and the necessary regulatory approvals. Financial terms were not disclosed.

The Valence Group is an investment bank that provides financial advisory services to the chemical industry, covering petrochemicals and commodities through to specialties, agrochemicals and adjacent materials and markets.

Headquartered in New York, the US group regards itself as the largest, wholly dedicated chemicals M&A advisor worldwide. Its client list includes companies such as SK Capital, Indorama Ventures, Arkema, Synthomer, Ineos Enterprises and Evonik, among many others.

“We and our team are excited about the collaboration with our new partners, and the acceleration in the growth of our chemicals and materials franchise that Piper Sandler will help to bring about under our continued leadership, not only in the US and Europe but throughout the world,” said The Valence Group’s co-founder Telly Zachariades.

The Valence Group will form Piper Sandler’s new chemicals group, retaining its business model and approach to transactions/execution.

“We believe there are significant opportunities to partner with The Valence Group team to increase the overall scale of the business and drive towards our goal of $1 billion in annual investment banking revenue over the next several years,” said James Baker, global co-head of investment banking at Piper Sandler.

The Valence Group’s team comprises 29 staff, including its four co-founders and five additional managing directors. Following the acquisition, co-founder Peter Hall will take up position as head of European investment banking and will lead Piper Sandler’s expansion of investment banking in Europe. This, said Piper Sandler, represents a meaningful opportunity to leverage The Valence Group’s expertise and leadership to build a stronger presence in Europe across multiple industry verticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.